Headquarter: Chemical Industry Park, Economic Development Zone,  JiNan City,  ShanDong Province, China.

Phone +86-152 8958 7728


genedrive Share Price, News & Analysis (LON:GDR) – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, which incorporates various user-led improvements to its small, patented gene amplification platform for ease of use in time critical situations, and to simplify workflow, as well as for professional use in emergency healthcare settings. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for targeting various pathogens in the defense applications; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive COV19-ID Kit, an innovative rapid point-of care molecular test for COVID-19. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Sign-up to receive the latest news and ratings for genedrive and its competitors with MarketBeat’s FREE daily newsletter.
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
genedrive’s stock was trading at GBX 11 at the beginning of 2023. Since then, GDR stock has decreased by 20.0% and is now trading at GBX 8.80.
View the best growth stocks for 2023 here
genedrive plc (LON:GDR) announced its earnings results on Tuesday, February, 4th. The company reported ($8.90) earnings per share (EPS) for the quarter.
Based on aggregate information from My MarketBeat watchlists, some companies that other genedrive investors own include NVIDIA (NVDA), Altria Group (MO), Netflix (NFLX), SolGold (SOLG), Tiziana Life Sciences (TILS), Asbury Automotive Group (ABG), Allena Pharmaceuticals (ALNA), Amphenol (APH), Benchmark Electronics (BHE) and Bank of New York Mellon (BK).
You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist.
Please log in to your account or sign up in order to add this asset to your watchlist.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.
My Account –


Leave a Reply

Your email address will not be published.